Published in Antioxid Redox Signal on February 01, 2009
Microglial activation and chronic neurodegeneration. Neurotherapeutics (2010) 1.87
Molecular mechanisms involving sigma receptor-mediated induction of MCP-1: implication for increased monocyte transmigration. Blood (2010) 1.44
NOX activity is increased in mild cognitive impairment. Antioxid Redox Signal (2010) 1.22
Targeting microglia-mediated neurotoxicity: the potential of NOX2 inhibitors. Cell Mol Life Sci (2012) 1.14
Reactive oxygen species drive herpes simplex virus (HSV)-1-induced proinflammatory cytokine production by murine microglia. J Neuroinflammation (2011) 1.05
Herpes simplex virus induces neural oxidative damage via microglial cell Toll-like receptor-2. J Neuroinflammation (2010) 1.05
Nox-4-dependent nuclear H2O2 drives DNA oxidation resulting in 8-OHdG as urinary biomarker and hemangioendothelioma formation. Antioxid Redox Signal (2010) 1.05
HIV-1 Tat co-operates with IFN-gamma and TNF-alpha to increase CXCL10 in human astrocytes. PLoS One (2009) 1.00
Roles and functions of HIV-1 Tat protein in the CNS: an overview. Virol J (2013) 0.99
Oxidative stress and cerebral endothelial cells: regulation of the blood-brain-barrier and antioxidant based interventions. Biochim Biophys Acta (2011) 0.98
NOX2 deficiency attenuates markers of adiposopathy and brain injury induced by high-fat diet. Am J Physiol Endocrinol Metab (2012) 0.98
Cooperative induction of CXCL10 involves NADPH oxidase: Implications for HIV dementia. Glia (2010) 0.96
Flipping the switches: CD40 and CD45 modulation of microglial activation states in HIV associated dementia (HAD). Mol Neurodegener (2011) 0.92
HIV neuropathogenesis: a tight rope walk of innate immunity. J Neuroimmune Pharmacol (2010) 0.92
Oxidative stress and the HIV-infected brain proteome. J Neuroimmune Pharmacol (2013) 0.92
Brain dysfunction in the era of combination antiretroviral therapy: implications for the treatment of the aging population of HIV-infected individuals. Curr Opin Investig Drugs (2010) 0.91
HIV-Tat elicits microglial glutamate release: role of NAPDH oxidase and the cystine-glutamate antiporter. Neurosci Lett (2010) 0.89
A growth factor attenuates HIV-1 Tat and morphine induced damage to human neurons: implication in HIV/AIDS-drug abuse cases. PLoS One (2011) 0.87
Modulation of experimental herpes encephalitis-associated neurotoxicity through sulforaphane treatment. PLoS One (2012) 0.86
Ibudilast, a pharmacologic phosphodiesterase inhibitor, prevents human immunodeficiency virus-1 Tat-mediated activation of microglial cells. PLoS One (2011) 0.84
HIV-1, reactive oxygen species, and vascular complications. Free Radic Biol Med (2012) 0.83
Cocaine potentiates cathepsin B secretion and neuronal apoptosis from HIV-infected macrophages. J Neuroimmune Pharmacol (2014) 0.83
Methionine sulfoxide reductase A negatively controls microglia-mediated neuroinflammation via inhibiting ROS/MAPKs/NF-κB signaling pathways through a catalytic antioxidant function. Antioxid Redox Signal (2015) 0.81
The cross-talk of HIV-1 Tat and methamphetamine in HIV-associated neurocognitive disorders. Front Microbiol (2015) 0.80
Primary murine microglia are resistant to nitric oxide inhibition of indoleamine 2,3-dioxygenase. Brain Behav Immun (2010) 0.78
ROS upregulation during the early phase of retroviral infection plays an important role in viral establishment in the host cell. J Gen Virol (2013) 0.78
Crosstalk between HDAC6 and Nox2-based NADPH oxidase mediates HIV-1 Tat-induced pro-inflammatory responses in astrocytes. Redox Biol (2017) 0.75
Fate of microglia during HIV-1 infection: From activation to senescence? Glia (2016) 0.75
Myeloid-specific deletion of NOX2 prevents the metabolic and neurologic consequences of high fat diet. PLoS One (2017) 0.75
Childhood maltreatment and HIV-associated neurocognitive disorders share similar pathophysiology: a potential sensitisation mechanism? Metab Brain Dis (2017) 0.75
Free radicals in the physiological control of cell function. Physiol Rev (2002) 19.62
Expression of HIV regulatory and structural mRNA in the central nervous system. AIDS (1996) 3.79
Immunocytochemical quantitation of human immunodeficiency virus in the brain: correlations with dementia. Ann Neurol (1995) 3.78
Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation. J Virol (1993) 3.68
Reactive microgliosis. Prog Neurobiol (1999) 3.55
Neurological complications of HIV infection. Lancet Neurol (2005) 3.25
Novel competitive inhibitor of NAD(P)H oxidase assembly attenuates vascular O(2)(-) and systolic blood pressure in mice. Circ Res (2001) 3.24
Characteristics of the inhibition of NADPH oxidase activation in neutrophils by apocynin, a methoxy-substituted catechol. Am J Respir Cell Mol Biol (1994) 3.23
The superoxide-generating NADPH oxidase: structural aspects and activation mechanism. Cell Mol Life Sci (2002) 3.22
NADPH oxidase mediates lipopolysaccharide-induced neurotoxicity and proinflammatory gene expression in activated microglia. J Biol Chem (2003) 2.92
Neuropsychological impairment in human immunodeficiency virus-infection: implications for employment. HNRC Group. HIV Neurobehavioral Research Center. Psychosom Med (1994) 2.39
Assembly of the phagocyte NADPH oxidase: molecular interaction of oxidase proteins. J Leukoc Biol (1996) 2.31
Neurologic manifestations of human immunodeficiency virus infection in children. Pediatrics (1986) 2.09
Neuropathology and neurodegeneration in human immunodeficiency virus infection. Pathogenesis of HIV-induced lesions of the brain, correlations with HIV-associated disorders and modifications according to treatments. Clin Neuropathol (2001) 2.09
Cells of the central nervous system as targets and reservoirs of the human immunodeficiency virus. Virus Res (2005) 2.09
Intracerebral cytokine messenger RNA expression in acquired immunodeficiency syndrome dementia. Ann Neurol (1993) 2.09
Human immunodeficiency virus type 1-infected monocytic cells can destroy human neural cells after cell-to-cell adhesion. Ann Neurol (1992) 2.04
HIV-1 Tat potentiates TNF-induced NF-kappa B activation and cytotoxicity by altering the cellular redox state. EMBO J (1995) 2.01
Redox regulation of glial inflammatory response to lipopolysaccharide and interferongamma. J Neurosci Res (2004) 1.97
Production of superoxide anions by a CNS macrophage, the microglia. FEBS Lett (1987) 1.83
Critical role of microglial NADPH oxidase-derived free radicals in the in vitro MPTP model of Parkinson's disease. FASEB J (2003) 1.81
Activation of NF kappa B by the respiratory burst of macrophages. Free Radic Biol Med (1996) 1.79
Nox2-derived reactive oxygen species mediate neurovascular dysregulation in the aging mouse brain. J Cereb Blood Flow Metab (2007) 1.79
Detection of the human immunodeficiency virus regulatory protein tat in CNS tissues. J Neurovirol (2000) 1.71
HIV tat and neurotoxicity. Microbes Infect (2006) 1.69
Microglia in diseases of the central nervous system. Ann Med (2002) 1.66
Activation of microglia by secreted amyloid precursor protein evokes release of glutamate by cystine exchange and attenuates synaptic function. J Neurochem (2001) 1.56
Fibrillar amyloid-beta peptides kill human primary neurons via NADPH oxidase-mediated activation of neutral sphingomyelinase. Implications for Alzheimer's disease. J Biol Chem (2004) 1.55
HIV-1 Tat and opiate-induced changes in astrocytes promote chemotaxis of microglia through the expression of MCP-1 and alternative chemokines. Glia (2006) 1.53
NF kappa B and AP-1 mediate transcriptional responses to oxidative stress in skeletal muscle cells. Free Radic Biol Med (2001) 1.51
Oxidative and antioxidative potential of brain microglial cells. Antioxid Redox Signal (2005) 1.48
Glutamate release from activated microglia requires the oxidative burst and lipid peroxidation. J Neurochem (2007) 1.46
Cerebrospinal fluid markers that predict SIV CNS disease. J Neuroimmunol (2004) 1.29
Expression of chemokines by human fetal microglia after treatment with the human immunodeficiency virus type 1 protein Tat. J Neurovirol (2004) 1.24
Macrophage-induced cytotoxicity of N-methyl-D-aspartate receptor positive neurons involves excitatory amino acids rather than reactive oxygen intermediates and cytokines. Eur J Immunol (1992) 1.23
Proteasome inhibition induces reversible impairments in protein synthesis. FASEB J (2006) 1.20
Glycated proteins stimulate reactive oxygen species production in cardiac myocytes: involvement of Nox2 (gp91phox)-containing NADPH oxidase. Circulation (2006) 1.20
The Tat protein of HIV-1 induces tumor necrosis factor-alpha production. Implications for HIV-1-associated neurological diseases. J Biol Chem (1997) 1.20
Unifying hypothesis for the pathogenesis of HIV-associated dementia complex, vacuolar myelopathy, and sensory neuropathy. J Acquir Immune Defic Syndr Hum Retrovirol (1995) 1.19
Pro-inflammatory and pro-oxidant properties of the HIV protein Tat in a microglial cell line: attenuation by 17 beta-estradiol. J Neurochem (2001) 1.17
HIV-1 Tat protein-induced alterations of ZO-1 expression are mediated by redox-regulated ERK 1/2 activation. J Cereb Blood Flow Metab (2005) 1.15
Anti-death properties of TNF against metabolic poisoning: mitochondrial stabilization by MnSOD. J Neuroimmunol (1999) 1.10
NeuroAIDS: contributions of the human immunodeficiency virus-1 proteins Tat and gp120 as well as CD40 to microglial activation. J Neurosci Res (2005) 1.07
The role of the immune system in neurodegenerative disorders. Mov Disord (1997) 0.98
Ability of rat microglia to uptake extracellular glutamate. Neurosci Lett (2001) 0.95
Multiple actions of the human immunodeficiency virus type-1 Tat protein on microglial cell functions. Neurochem Res (2004) 0.94
Activation of human microglial cells by HIV-1 gp41 and Tat proteins. Clin Immunol (2000) 0.90
A novel class of cytochrome P450 reductase redox cyclers: cationic manganoporphyrins. Toxicol Sci (2005) 0.90
Bone marrow-derived endothelial progenitor cells are a major determinant of nascent tumor neovascularization. Genes Dev (2007) 2.60
Cognitive impairment following high fat diet consumption is associated with brain inflammation. J Neuroimmunol (2009) 1.82
Effects of high fat diet on Morris maze performance, oxidative stress, and inflammation in rats: contributions of maternal diet. Neurobiol Dis (2009) 1.80
Ribosome dysfunction is an early event in Alzheimer's disease. J Neurosci (2005) 1.80
RNA in brain disease: no longer just "the messenger in the middle". J Neuropathol Exp Neurol (2007) 1.57
HIV-1 Tat and opiate-induced changes in astrocytes promote chemotaxis of microglia through the expression of MCP-1 and alternative chemokines. Glia (2006) 1.53
Human cerebral neuropathology of Type 2 diabetes mellitus. Biochim Biophys Acta (2008) 1.46
High fat diet increases hippocampal oxidative stress and cognitive impairment in aged mice: implications for decreased Nrf2 signaling. J Neurochem (2010) 1.43
Abeta solubility and deposition during AD progression and in APPxPS-1 knock-in mice. Neurobiol Dis (2007) 1.40
Synaptic transport of human immunodeficiency virus-Tat protein causes neurotoxicity and gliosis in rat brain. J Neurosci (2003) 1.35
Proteasome regulation of oxidative stress in aging and age-related diseases of the CNS. Antioxid Redox Signal (2006) 1.33
Obesity and vulnerability of the CNS. Biochim Biophys Acta (2008) 1.29
Proteasome inhibition alters neural mitochondrial homeostasis and mitochondria turnover. J Biol Chem (2004) 1.27
Chronic exercise modulates RAS components and improves balance between pro- and anti-inflammatory cytokines in the brain of SHR. Basic Res Cardiol (2011) 1.24
NOX activity is increased in mild cognitive impairment. Antioxid Redox Signal (2010) 1.22
Morphine and HIV-Tat increase microglial-free radical production and oxidative stress: possible role in cytokine regulation. J Neurochem (2008) 1.22
Elevated levels of 3-nitrotyrosine in brain from subjects with amnestic mild cognitive impairment: implications for the role of nitration in the progression of Alzheimer's disease. Brain Res (2007) 1.21
Saturated long-chain fatty acids activate inflammatory signaling in astrocytes. J Neurochem (2012) 1.21
Morphine exacerbates HIV-1 Tat-induced cytokine production in astrocytes through convergent effects on [Ca(2+)](i), NF-kappaB trafficking and transcription. PLoS One (2008) 1.21
Decreased RNA, and increased RNA oxidation, in ribosomes from early Alzheimer's disease. Neurochem Res (2006) 1.21
Proteasome inhibition induces reversible impairments in protein synthesis. FASEB J (2006) 1.20
Cytochrome c release and caspase activation after traumatic brain injury. Brain Res (2002) 1.20
Protein oxidation and cellular homeostasis: Emphasis on metabolism. Biochim Biophys Acta (2006) 1.19
Characterization of chronic low-level proteasome inhibition on neural homeostasis. J Neurochem (2003) 1.18
Oral fixed drug eruption due to fluconazole. Indian J Dermatol Venereol Leprol (2006) 1.16
Regulation of energy metabolism by inflammation: a feedback response in obesity and calorie restriction. Aging (Albany NY) (2010) 1.16
Oxidative stress, neurodegeneration, and the balance of protein degradation and protein synthesis. Free Radic Biol Med (2012) 1.13
The tumor suppressor interferon regulatory factor 1 interferes with SP1 activation to repress the human CDK2 promoter. J Biol Chem (2003) 1.12
Impact of opiate-HIV-1 interactions on neurotoxic signaling. J Neuroimmune Pharmacol (2006) 1.11
Estrogen and brain inflammation: effects on microglial expression of MHC, costimulatory molecules and cytokines. J Neuroimmunol (2005) 1.10
Ump1 extends yeast lifespan and enhances viability during oxidative stress: central role for the proteasome? Free Radic Biol Med (2005) 1.10
Role of the proteasome in protein oxidation and neural viability following low-level oxidative stress. FEBS Lett (2003) 1.09
Non-redox-active lipoate derivates disrupt cancer cell mitochondrial metabolism and are potent anticancer agents in vivo. J Mol Med (Berl) (2011) 1.09
Cell-specific actions of HIV-Tat and morphine on opioid receptor expression in glia. J Neurosci Res (2008) 1.09
Body mass index and the risk of dementia among Louisiana low income diabetic patients. PLoS One (2012) 1.07
Polyglutamine expansion, protein aggregation, proteasome activity, and neural survival. J Biol Chem (2002) 1.06
Oxidative inactivation of the proteasome in Alzheimer's disease. Free Radic Res (2007) 1.04
CCR2 mediates increases in glial activation caused by exposure to HIV-1 Tat and opiates. J Neuroimmunol (2006) 1.04
Development of diet-induced insulin resistance in adult Drosophila melanogaster. Biochim Biophys Acta (2012) 1.04
Fixed drug eruption caused by ornidazole. Contact Dermatitis (2005) 1.03
Colletotrichum truncatum: an unusual pathogen causing mycotic keratitis and endophthalmitis. J Clin Microbiol (2011) 1.03
CCL5/RANTES gene deletion attenuates opioid-induced increases in glial CCL2/MCP-1 immunoreactivity and activation in HIV-1 Tat-exposed mice. J Neuroimmune Pharmacol (2008) 1.02
Subcutaneous and intramuscular cysticercosis: high-resolution sonography. Indian J Dermatol Venereol Leprol (2009) 1.02
HIV-1 Tat and morphine have interactive effects on oligodendrocyte survival and morphology. Glia (2009) 1.02
Mesenchymal chondrosarcoma of maxilla: a rare case report. Med Oral Patol Oral Cir Bucal (2011) 1.01
LMP2 knock-out mice have reduced proteasome activities and increased levels of oxidatively damaged proteins. Antioxid Redox Signal (2006) 1.00
Effects of short-term Western diet on cerebral oxidative stress and diabetes related factors in APP x PS1 knock-in mice. J Neurochem (2008) 1.00
Splice variants of the receptor for advanced glycosylation end products (RAGE) in human brain. Neurosci Lett (2005) 1.00
Alpha-synuclein alters proteasome function, protein synthesis, and stationary phase viability. J Biol Chem (2005) 1.00
Oxidative stress and cerebral endothelial cells: regulation of the blood-brain-barrier and antioxidant based interventions. Biochim Biophys Acta (2011) 0.98
NOX2 deficiency attenuates markers of adiposopathy and brain injury induced by high-fat diet. Am J Physiol Endocrinol Metab (2012) 0.98
Aging is associated with hypoxia and oxidative stress in adipose tissue: implications for adipose function. Am J Physiol Endocrinol Metab (2011) 0.97
NOX activity in brain aging: exacerbation by high fat diet. Free Radic Biol Med (2010) 0.97
Aging and dietary restriction alter proteasome biogenesis and composition in the brain and liver. Mech Ageing Dev (2009) 0.96
Intersection between metabolic dysfunction, high fat diet consumption, and brain aging. J Neurochem (2010) 0.96
Consensus physical activity guidelines for Asian Indians. Diabetes Technol Ther (2011) 0.96
4-Hydroxynonenal oxidatively modifies histones: implications for Alzheimer's disease. Neurosci Lett (2004) 0.95
Oxidative damage, protein synthesis, and protein degradation in Alzheimer's disease. Curr Alzheimer Res (2007) 0.95
A strategically designed small molecule attacks alpha-ketoglutarate dehydrogenase in tumor cells through a redox process. Cancer Metab (2014) 0.95
Evaluation of rage isoforms, ligands, and signaling in the brain. Biochim Biophys Acta (2005) 0.94
Feasibility, reliability, and validity of a smartphone based application for the assessment of cognitive function in the elderly. PLoS One (2013) 0.94
PTEN-mediated AKT activation contributes to the reduced apoptosis among Indian oral squamous cell carcinoma patients. J Cancer Res Clin Oncol (2011) 0.93
Prodynorphin storage and processing in axon terminals and dendrites. FASEB J (2006) 0.93
Aging and dietary restriction effects on ubiquitination, sumoylation, and the proteasome in the heart. Mech Ageing Dev (2008) 0.93
Cavitary pulmonary zygomycosis caused by Rhizopus homothallicus. J Clin Microbiol (2010) 0.92
The stationary phase model of aging in yeast for the study of oxidative stress and age-related neurodegeneration. Biogerontology (2005) 0.92
Cognitive impairment in humanized APP×PS1 mice is linked to Aβ(1-42) and NOX activation. Neurobiol Dis (2011) 0.91
Interplay between protein synthesis and degradation in the CNS: physiological and pathological implications. Trends Neurosci (2006) 0.91
The neuregulin GGF2 attenuates free radical release from activated microglial cells. J Neuroimmunol (2003) 0.91
Diet-induced metabolic disturbances as modulators of brain homeostasis. Biochim Biophys Acta (2008) 0.91
Retracted Nucleoside reverse transcriptase inhibitors prevent HIV protease inhibitor-induced atherosclerosis by ubiquitination and degradation of protein kinase C. Am J Physiol Cell Physiol (2006) 0.91